ABSTRACT

Contrast nephropathy is a major and growing problem. It is the third most common cause of in-hospital acute renal failure and is associated with significant in-hospital mortality, long-term mortality, increased risk of in-hospital major adverse cardiac events as well as prolonged hospital stay and increased costs of health care.



The first of its kind to discuss the potentially mortal problems with contrast agent-induced nephropathy, this important work focuses on the challenge of contrast nephropathy in patients undergoing diagnostic and interventional procedures in the cardiac catheterization laboratory, such as coronary and peripheral angiography, percutaneous coronary and peripheral interventions.



Bringing together experts from the specialties and subspecialties of cardiology, interventional cardiology, radiology and nephrology, Contrast-Induced Nephropathy is a useful resource not only for interventional cardiologists but also for other professionals involved in the care of high-risk patients undergoing contrast-associated procedures.

chapter |3 pages

SECTION I

chapter |9 pages

Pathophysiology of CIN

part |1 pages

Pathophysiology in the prevention of CIN by hydration

chapter |10 pages

References

part |1 pages

Risk factors for contrast-induced nephropathy

part 3|1 pages

Clinical features and prognostic implications of contrast-induced nephropathy

chapter |8 pages

Clinical characteristics

chapter |3 pages

References

chapter 6|9 pages

Introduction

ENOVASCULAR DISEASE IN PATIENTS WITH CORONARY ARTERY DISEASE Michael H Duong, Craig A Thompson, and Aaron V Kaplan

chapter |9 pages

SECTION II

part |1 pages

References

chapter |10 pages

Physiologic effects

chapter |4 pages

References

chapter |9 pages

Antioxidant strategy

chapter |13 pages

References

chapter |16 pages

Treatment of CIN-induced ARF by RRT